Search the Newsreel

Smartlink Holdings Limited Reports Strong Q1 FY27 Performance with Consolidated Total Income Reaching ₹10,124.77 Lakhs

Gains from equipment sales save Heartland’s Q2

Heartland Express (NASDAQ: HTLD) returned to profitability in Q2, reporting a net income of $10.6 million, or 14 cents per share. This turnaround was primarily driven by a $22 million year-over-year increase in gains from equipment sales, as the company strategically disposed of underutilized …

Press Release: Heartland Express, Inc. Reports Net Income and Financial Results for the Second Quarter of 2026

Heartland Express, Inc. announced its financial results for the second quarter of 2026, reporting net income and providing detailed financial figures. This press release outlines the company's performance, offering insight into its profitability and overall financial health during the period. Investors and stakeholders can …

Smartlink Holdings Limited Reports Earnings Results for the First Quarter Ended June 30, 2026

Heartland Express earnings beat by $0.14, revenue fell short of estimates

Heartland Express GAAP EPS of $0.14 beats by $0.15, revenue of $184.13M misses by $7.33M

* Heartland Express press release [https://seekingalpha.com/pr/20601513-heartland-express-inc-reports-net-income-and-financial-results-for-the-second-quarter-of-2026] (HTLD [https://seekingalpha.com/symbol/HTLD]): Q2 GAAP EPS of $0.14 beats by $0.15. * Revenue of $184.13M (-12.5% Y/Y) misses by $7.33M. * _Operating Ratio of __91.0%__ (a 1,490bp improvement to Q2 2025) and __88.3%__ Non-GAAP Adjusted Operating Ratio._ MORE ON …

Heartland Express (NASDAQ:HTLD) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings

Heartland Express (NASDAQ:HTLD) reported Q2 CY2026 earnings, missing Wall Street's revenue expectations with sales falling 12.5% year-on-year to $184.1 million. However, the company's non-GAAP profit of $0.14 per share significantly exceeded analyst consensus estimates. Despite the revenue miss, the company showed significant operating ratio …

Heartland Express Q2 Results: EPS beats, sales miss

Heartland Express (NASDAQ: HTLD) reported a mixed second quarter, with earnings per share (EPS) of $0.14 significantly beating the analyst estimate of $(0.02) and reversing a prior-year loss. However, the company's sales of $184.100 million missed the $192.443 million estimate by 4.34% and saw …

Heartland Express, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Heartland Express cuts acquisition debt and leases to $135M

Heartland Express reported a return to profitability in Q2 2026, with a net income of $10.6 million compared to a net loss in the prior year, and a significantly improved operating ratio. The company also substantially reduced its acquisition-related debt and finance lease obligations …

Earnings Flash (HTLD) Heartland Express, Inc. Reports Q2 Revenue $184.1M, vs. FactSet Est of $185.1M

Heartland Express, Inc. (HTLD) reported its Q2 revenue at $184.1 million, falling slightly short of the FactSet estimate of $185.1 million. The company's shares experienced a decline following the revenue announcement. This financial update indicates a marginal miss on revenue expectations for the quarter.

Heartland Express (HTLD) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Heartland Express (HTLD) reported its Q2 2026 earnings, with revenue of $184.13 million, a 12.5% decrease year-over-year, and EPS of $0.14. The reported revenue missed the Zacks Consensus Estimate, while EPS was higher than the zero estimate. Key metrics like operating ratio and fuel …

Heartland Express Shares Fall After Revenue Declines

Heartland Express (HTLD) Following The Pullback, Is The Valuation Story Still Mixed?

Heartland Express (HTLD) has experienced a recent stock pullback, down 14% over the last month, yet still showing strong year-to-date and 1-year returns. The company's valuation presents a mixed picture, with a Price-to-Sales (P/S) ratio of 1.4x appearing to be good value against peers …

Price to earnings forward of Artelo Biosciences, Inc. – NASDAQ:ARTL

This article provides a brief overview of the "Price to earnings forward" metric for Artelo Biosciences, Inc. (NASDAQ: ARTL). It appears to be a financial data snippet from a larger platform, indicating the period, value, and change for this specific financial ratio. The metadata …

Artelo Biosciences, Inc. Revenue Breakdown – NASDAQ:ARTL

This article provides access to the financial overview of Artelo Biosciences, Inc. (NASDAQ: ARTL) through TradingView. It highlights where to find financials, statements, and other fundamental data for the company. The content primarily serves as a gateway to financial data and analysis tools for …

Heartland Express earnings up next: Can trucker return to profit?

Heartland Express (NASDAQ:HTLD) is set to report its second-quarter earnings, with analysts expecting a narrow profit after recent losses, indicating a potential turnaround. Investors will be focused on whether the truckload carrier can achieve sustained profitability amidst signs of freight demand recovery and capacity …

Heartland Group Holdings (ASX:HGH) Dividend Profile in Focus as 4.61% Yield Supports Banking Income Appeal

Heartland Express Inc (HTLD) Income Statement

This article provides the quarterly and annual income statements for Heartland Express Inc (HTLD), detailing their financial performance over several fiscal years. It includes key figures such as total revenue, operating expenses, operating profit, net income, and earnings per share. The information is presented …

Heartland Express Inc (HTLD) Cash Flow

This article provides a detailed cash flow statement for Heartland Express Inc (HTLD), covering quarterly and annual data for operating, investing, and financing activities. It also includes FAQs defining these cash flow types and detailing HTLD's performance in each area for recent periods. The …

Heartland Express, Inc. Revenue Breakdown – TRADEGATE:HLX

Heartland Express, Inc. generated €686.00 million in revenue last year, primarily from its Truckload Services segment. This represents a decrease from the prior year's revenue of €1.01 billion. The United States was the company's largest regional contributor to revenue.

Artelo Biosciences Inc ARTL Cash Flow Statement

This article provides a detailed quarterly and annual cash flow statement for Artelo Biosciences Inc (ARTL), covering operating, investing, and financing activities across multiple fiscal years. It includes key financial figures and year-over-year percentage changes, enabling an evaluation of the company's financial health. The …

Heartland Express Inc (HTLD) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Heartland Express Inc (HTLD), outlining major shareholders such as Michael J. Gerdin and BlackRock, along with the proportions held by various shareholder types like investment advisors and individual investors. It also presents institutional shareholding data over several …

Heartland Express Inc (HTLD) Valuation: PE, PB & Fair Value Analysis

This article provides an analysis of Heartland Express Inc (HTLD)'s valuation, highlighting its current valuation score of 9.08, which ranks 15th out of 75 in its industry. The company's P/E ratio is noted as -25.54, indicating a significant deviation from recent highs and lows. …

ARTL|Artelo Biosciences Inc|Price:1.020|Chg%:-0.040

Artelo Biosciences Inc. (ARTL) is a clinical-stage pharmaceutical company focused on developing therapies that modulate lipid-signaling pathways for various conditions. Despite facing a weak stock market performance recently, the company exhibits strong fundamentals and high growth potential with a fairly valued stock. Analysts currently …

HTLD|Heartland Express Inc|Price:14.280|Chg%:-0.550

Heartland Express Inc (HTLD) is currently trading at $14.280, reflecting a 3.71% decrease from its previous close. Despite a recent weak stock market performance, the company's fundamentals are considered healthy with significant growth potential, although its valuation is seen as fairly valued within the …

Heartland Express Inc (HTLD) Technical Analysis: Support, Resistance, Indicators & Moving Averages

Heartland Express Inc (HTLD) currently has a price momentum score of 2.75, ranking 72 out of 75 in its industry. The stock is trading between a resistance level of 15.23 and a support level of 13.68, suggesting suitability for range-bound swing trading. Technical indicators …

Asian Penny Stock Picks Featuring Heartland Group Holdings And Two Others

Do Options Traders Know Something About Heartland Express Stock We Don't?

Heartland Express (HTLD) is showing high implied volatility in its options market, particularly for the Sept. 18, 2026 $2.5 Call. This suggests options traders are anticipating a significant price movement in the stock. Analysts currently rate Heartland Express as a Zacks Rank #1 (Strong …

Best Momentum Stocks to Buy for July 22nd

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, July 22: Heartland Express, Inc. HTLD: This truckload transportation company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 100% …

Review of 50+ CBD studies finds drug interactions in retail products

A review of over 50 studies on low-dose cannabidiol (CBD) products, published in the British Journal of Clinical Pharmacology and led by an Artelo scientist, found that common over-the-counter CBD doses (≤2.5 mg/kg or ≤175 mg/day) yielded little to no therapeutic effect and had …

New Analysis of Over 50 Studies Showed that All the Non-Prescription CBD Products Researched Fell Short of Therapeutic Efficacy — Reinforcing the Case for Artelo's Optimized ART12.11 CBD Composition

A new peer-reviewed article in the British Journal of Clinical Pharmacology, co-authored by Artelo Biosciences, reveals that over 50 studies found low-dose non-prescription CBD products lack therapeutic efficacy due to insufficient exposure. Artelo's optimized CBD composition, ART12.11, aims to address this challenge by improving …

Heartland Express (HTLD) Q2 2025 earnings summary

Heartland Express (HTLD) reported a challenging Q2 2025 with operating revenue down 23.4% year-over-year to $210.4 million and a net loss of $10.9 million. The company attributes this to weak freight demand, excess capacity, and unsustainable pricing, with no significant improvement expected until later …

New Strong Buy Stocks for July 22nd

This article lists five stocks that have been added to Zacks' #1 (Strong Buy) List for July 22nd. These companies, including Heartland Express, Yext, Anixa Biosciences, Wave Life Sciences, and LCNB Corp., have all seen significant increases in their current year earnings estimates over …

Artelo Biosciences (NASDAQ: ARTL) awards 136-share option to director

Artelo Biosciences (NASDAQ: ARTL) director Steven Kelly was granted stock options for 136 shares at an exercise price of $1.15 per share. The options will vest 100% on the earlier of one year from July 17, 2026, or the day before the next annual …

Artelo Biosciences (ARTL) grants small stock option award to director

Artelo Biosciences (ARTL) has granted a stock option covering 136 shares to director Connie Matsui, with an exercise price of $1.15 per share and an expiration date of July 17, 2036. The options will vest 100% on the earlier of one year from the …